APA

Sharma S., Babiker A. G., Emery S., Gordin F. M., Lundgren J. D., Neaton J. N., Bakowska E., Schechter M., Wiselka M. J. & Wolff M. J. (20151104). Demographic and HIV-specific characteristics of participants enrolled in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. : HIV medicine.

Chicago

Sharma S, Babiker A G, Emery S, Gordin F M, Lundgren J D, Neaton J N, Bakowska E, Schechter M, Wiselka M J and Wolff M J. 20151104. Demographic and HIV-specific characteristics of participants enrolled in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. : HIV medicine.

Harvard

Sharma S., Babiker A. G., Emery S., Gordin F. M., Lundgren J. D., Neaton J. N., Bakowska E., Schechter M., Wiselka M. J. and Wolff M. J. (20151104). Demographic and HIV-specific characteristics of participants enrolled in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. : HIV medicine.

MLA

Sharma S, Babiker A G, Emery S, Gordin F M, Lundgren J D, Neaton J N, Bakowska E, Schechter M, Wiselka M J and Wolff M J. Demographic and HIV-specific characteristics of participants enrolled in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. : HIV medicine. 20151104.